The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Iron metabolism: pathophysiology and pharmacology
Open accessAbstract
Iron is essential in many physiological processes, including DNA metabolism, oxygen transport, and cellular energy generation. Deregulated iron metabolism, which results in iron overload or iron deficiency, is observed in many different diseases. We here summarize recent progress in the pathophysiology and pharmacology of iron-overload diseases, such as hereditary hemochromatosis, as well as iron-deficiency disorders, which are typically associated with anemia. The role of iron in immunity and the connection between iron and cancer are also addressed. We finally summarize and discuss the current (pre-) clinical landscape of pharmacotherapies targeting key players involved in iron metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32064-5 · Cited by 3,842
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Cloning and characterization of a mammalian proton-coupled metal-ion transporter
Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., & Hediger, M. A. (1997) · Nature · doi:10.1038/41343 · Cited by 3,166
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 1×
“Additionally, inflammatory cytokines such as interleukin 6 (IL-6) induce hepcidin biosynthesis and reduce plasma iron levels as a preventive measure against bacterial growth [15].”
BackgroundThe role of iron and reactive oxygen species in cell death
Dixon, S. J., & Stockwell, B. R. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1416 · Cited by 2,381
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., Thomas, A. G., Gleason, C. E., Tatonetti, N. P., Slusher, B. S., et al. (2014) · eLife · doi:10.7554/elife.02523 · Cited by 2,088
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., & Aderem, A. (2004) · Nature · doi:10.1038/nature03104 · Cited by 1,877
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Camaschella, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1401038 · Cited by 1,678
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
McKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
Ganz, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2013 · Cited by 1,122
Valsesia, A., Wang, Q.-P., Gheldof, N., Carayol, J., Ruffieux, H., Clark, T., Shenton, V., Oyston, L. J., Lefebvre, G., Metairon, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08492-8 · Cited by 1,073
Papanikolaou, G., & Pantopoulos, K. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.06.021 · Cited by 1,070
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026
Iron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology · doi:10.1038/nri3863 · Cited by 843
Chemistry and biology of eukaryotic iron metabolism
Aisen, P. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00063-2 · Cited by 804
Iron-Responsive Elements: Regulatory RNA Sequences That Control mRNA Levels and Translation
Casey, J. L., Hentze, M. W., Koeller, D. M., Caughman, S. W., Rouault, T. A., Klausner, R. D., & Harford, J. B. (1988) · Science · doi:10.1126/science.2452485 · Cited by 709
RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer
Sui, X., Zhang, R., Liu, S., Duan, T., Zhai, L., Zhang, M., Han, X., Xiang, Y., Huang, X., Lin, H., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01371 · Cited by 703
Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)
Peyssonnaux, C., Zinkernagel, A. S., Schuepbach, R. A., Rankin, E., Vaulont, S., Haase, V. H., Nizet, V., & Johnson, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31370 · Cited by 639
Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo
Rankin, E. B., Biju, M. P., Liu, Q., Unger, T. L., Rha, J., Johnson, R. S., Simon, M. C., Keith, B., & Haase, V. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30117 · Cited by 596
Hentze, M. W., Caughman, S. W., Rouault, T. A., Barriocanal, J. G., Dancis, A., Harford, J. B., & Klausner, R. D. (1987) · Science · doi:10.1126/science.3685996 · Cited by 571
Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
Li, L., Fang, C. J., Ryan, J. C., Niemi, E. C., Lebrón, J. A., Björkman, P. J., Arase, H., Torti, F. M., Torti, S. V., Nakamura, M. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913192107 · Cited by 561
Moretti, D., Goede, J. S., Zeder, C., Jiskra, M., Chatzinakou, V., Tjalsma, H., Melse-Boonstra, A., Brittenham, G., Swinkels, D. W., & Zimmermann, M. B. (2015) · Blood · doi:10.1182/blood-2015-05-642223 · Cited by 547
Cappellini, M. D., Comin‐Colet, J., de Francisco, A., Dignass, A., Doehner, W., Lam, C. S., Macdougall, I. C., Rogler, G., Camaschella, C., Kadir, R., et al. (2017) · American Journal of Hematology · doi:10.1002/ajh.24820 · Cited by 502
Inflammatory processes in cardiovascular disease: a route to targeted therapies
Ruparelia, N., Chai, J. T., Fisher, E. A., & Choudhury, R. P. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.185 · Cited by 477
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
Babitt, J. L., Huang, F. W., Xia, Y., Sidis, Y., Andrews, N. C., & Lin, H. Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31342 · Cited by 457
Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway
Cohen, L. A., Gutierrez, L., Weiss, A., Leichtmann-Bardoogo, Y., Zhang, D.-L., Crooks, D. R., Sougrat, R., Morgenstern, A., Galy, B., Hentze, M. W., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253815 · Cited by 452 · cited 1×
“Ferritin, the iron storage protein, is commonly cytosolic but can be excreted by macrophages and serve as an additional iron source [55].”
BackgroundFerroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Pinnix, Z. K., Miller, L. D., Wang, W., D’Agostino, R., Kute, T., Willingham, M. C., Hatcher, H., Tesfay, L., Sui, G., Di, X., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001127 · Cited by 448
Shah, Y. M., Matsubara, T., Ito, S., Yim, S.-H., & Gonzalez, F. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.012 · Cited by 431
COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review
Cavezzi, A., Troiani, E., & Corrao, S. (2020) · Clinics and Practice · doi:10.4081/cp.2020.1271 · Cited by 430
Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N., & Torti, F. M. (2018) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082117-051732 · Cited by 426
Portsmouth, S., van Veenhuyzen, D., Echols, R., Machida, M., Ferreira, J. C. A., Ariyasu, M., Tenke, P., & Nagata, T. D. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30554-1 · Cited by 420
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood · doi:10.1182/blood-2006-12-065433 · Cited by 409
Angelucci, E., Matthes-Martin, S., Baronciani, D., Bernaudin, F., Bonanomi, S., Cappellini, M. D., Dalle, J.-H., Di Bartolomeo, P., de Heredia, C. D., Dickerhoff, R., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.099747 · Cited by 399
Identification of a hypoxia response element in the transferrin receptor gene
Lok, C. N., & Ponka, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24147 · Cited by 380
Transferrin Receptor Induction by Hypoxia
Tacchini, L., Bianchi, L., Bernelli-Zazzera, A., & Cairo, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24142 · Cited by 379
Erratum: Inflammatory processes in cardiovascular disease: a route to targeted therapies
Ruparelia, N., Chai, J. T., Fisher, E. A., & Choudhury, R. P. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.33 · Cited by 363
Lipocalin 2 promotes breast cancer progression
Yang, J., Bielenberg, D. R., Rodig, S. J., Doiron, R., Clifton, M. C., Kung, A. L., Strong, R. K., Zurakowski, D., & Moses, M. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810617106 · Cited by 356
Scara5 Is a Ferritin Receptor Mediating Non-Transferrin Iron Delivery
Li, J. Y., Paragas, N., Ned, R. M., Qiu, A., Viltard, M., Leete, T., Drexler, I. R., Chen, X., Sanna-Cherchi, S., Mohammed, F., et al. (2009) · Developmental Cell · doi:10.1016/j.devcel.2008.12.002 · Cited by 353
TRANSFER OF IRON FROM SERUM IRON-BINDING PROTEIN TO HUMAN RETICULOCYTES*
Jandl, J. H., Inman, J. K., Simmons, R. L., & Allen, D. W. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103786 · Cited by 353
Targeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352
Self-citationPreferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
Schonberg, D. L., Miller, T. E., Wu, Q., Flavahan, W. A., Das, N. K., Hale, J. S., Hubert, C. G., Mack, S. C., Jarrar, A. M., Karl, R. T., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.002 · Cited by 349
A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia.
Cappellini, M. D., Viprakasit, V., Taher, A. T., Georgiev, P., Kuo, K. H. M., Coates, T., Voskaridou, E., Liew, H.-K., Pazgal-Kobrowski, I., Forni, G. L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1910182 · Cited by 332
Gao, J., Chen, J., Kramer, M., Tsukamoto, H., Zhang, A.-S., & Enns, C. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.010 · Cited by 326
Cancer cells deploy lipocalin-2 to collect limiting iron in leptomeningeal metastasis.
Chi, Y., Remsik, J., Kiseliovas, V., Derderian, C., Sener, U., Alghader, M., Saadeh, F., Nikishina, K., Bale, T., Iacobuzio-Donahue, C., et al. (2020) · Science · doi:10.1126/science.aaz2193 · Cited by 320
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
Trujillo-Alonso, V., Pratt, E. C., Zong, H., Lara-Martinez, A., Kaittanis, C., Rabie, M. O., Longo, V., Becker, M. W., Roboz, G. J., Grimm, J., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0406-1 · Cited by 319
Vinchi, F., Porto, G., Simmelbauer, A., Altamura, S., Passos, S. T., Garbowski, M., Silva, A. M. N., Spaich, S., Seide, S. E., Sparla, R., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz112 · Cited by 304
Iron in Neurodegeneration – Cause or Consequence?
Ndayisaba, A., Kaindlstorfer, C., & Wenning, G. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00180 · Cited by 298
Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions
Dignass, A., Farrag, K., & Stein, J. (2018) · International Journal of Chronic Diseases · doi:10.1155/2018/9394060 · Cited by 286
Anemia: progress in molecular mechanisms and therapies
Sankaran, V. G., & Weiss, M. J. (2015) · Nature Medicine · doi:10.1038/nm.3814 · Cited by 281
New insights into iron deficiency and iron deficiency anemia
Camaschella, C. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.02.004 · Cited by 278
Erythroferrone inhibits the induction of hepcidin by BMP6
Arezes, J., Foy, N., McHugh, K., Sawant, A., Quinkert, D., Terraube, V., Brinth, A., Tam, M., LaVallie, E. R., Taylor, S., et al. (2018) · Blood · doi:10.1182/blood-2018-06-857995 · Cited by 277
Ganz, T. (2018) · International Journal of Hematology · doi:10.1007/s12185-017-2366-2 · Cited by 270
Vinchi, F., Costa da Silva, M., Ingoglia, G., Petrillo, S., Brinkman, N., Zuercher, A., Cerwenka, A., Tolosano, E., & Muckenthaler, M. U. (2016) · Blood · doi:10.1182/blood-2015-08-663245 · Cited by 269
Taylor, M., Qu, A., Anderson, E. R., Matsubara, T., Martin, A., Gonzalez, F. J., & Shah, Y. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.007 · Cited by 265
Xue, X., Ramakrishnan, S. K., Weisz, K., Triner, D., Xie, L., Attili, D., Pant, A., Győrffy, B., Zhan, M., Carter-Su, C., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.015 · Cited by 245
Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis
Handa, P., Thomas, S., Morgan-Stevenson, V., Maliken, B. D., Gochanour, E., Boukhar, S., Yeh, M. M., & Kowdley, K. V. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0318-108r · Cited by 217
Iron and Reactive Oxygen Species: Friends or Foes of Cancer Cells?
Bystrom, L. M., Guzman, M. L., & Rivella, S. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5014 · Cited by 212
Schwartz, A. J., Das, N. K., Ramakrishnan, S. K., Jain, C., Jurkovic, M. T., Wu, J., Nemeth, E., Lakhal-Littleton, S., Colacino, J. A., & Shah, Y. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122359 · Cited by 203
Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
Edeas, M., Saleh, J., & Peyssonnaux, C. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.110 · Cited by 194
Alpha-Synuclein Is a Cellular Ferrireductase
Davies, P., Moualla, D., & Brown, D. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015814 · Cited by 183
Current misconceptions in diagnosis and management of iron deficiency.
Múñoz, M., Gómez‐Ramírez, S., Besser, M. W., Pavía, J., Gomollón, F., Liumbruno, G. M., Bhandari, S., Cladellas, M., Shander, A., & Auerbach, M. (2017) · PubMed · doi:10.2450/2017.0113-17 · Cited by 168
Iron induces anti-tumor activity in tumor-associated macrophages
Costa da Silva, M., Breckwoldt, M. O., Vinchi, F., Correia, M. P., Stojanovic, A., Thielmann, C. M., Meister, M., Muley, T., Warth, A., Platten, M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01479 · Cited by 164 · cited 1×
“, that iron delivery to TAM mediates a shift from an M2-like to an M1-like phenotype, which is accompanied by an enhanced anti-tumoral effect [108]–[110].”
BackgroundMastrogiannaki, M., Matak, P., Mathieu, J. R. R., Delga, S., Mayeux, P., Vaulont, S., & Peyssonnaux, C. (2012) · Haematologica · doi:10.3324/haematol.2011.056119 · Cited by 161
Targeting cancer by binding iron: Dissecting cellular signaling pathways
Lui, G. Y. L., Kovacevic, Z., Richardson, V., Merlot, A. M., Kalinowski, D. S., & Richardson, D. R. (2015) · Oncotarget · doi:10.18632/oncotarget.4349 · Cited by 161
New insights into the role of iron in inflammation and atherosclerosis
Cornelissen, A., Guo, L., Sakamoto, A., Virmani, R., & Finn, A. V. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.014 · Cited by 158
Biological Functions and Therapeutic Potential of Lipocalin 2 in Cancer
Santiago-Sánchez, G. S., Pita-Grisanti, V., Quiñones-Díaz, B., Gumpper, K., Cruz-Monserrate, Z., & Vivas-Mejía, P. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124365 · Cited by 158
Renal clearable nanochelators for iron overload therapy
Kang, H., Han, M., Xue, J., Baek, Y., Chang, J., Hu, S., Nam, H., Jo, M. J., Fakhri, G. E., Hutchens, M. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13143-z · Cited by 152
Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals
Grillo, A. S., SantaMaria, A. M., Kafina, M. D., Cioffi, A. G., Huston, N. C., Han, M., Seo, Y. A., Yien, Y. Y., Nardone, C., Menon, A. V., et al. (2017) · Science · doi:10.1126/science.aah3862 · Cited by 149
Nrf2 controls iron homoeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin
Lim, P. J., Duarte, T. L., Arezes, J., Garcia-Santos, D., Hamdi, A., Pasricha, S.-R., Armitage, A. E., Mehta, H., Wideman, S., Santos, A. G., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0063-6 · Cited by 147
Franceschi, L. D., Iolascon, A., Taher, A. T., & Cappellini, M. D. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.04.018 · Cited by 126
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
Naldini, L. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201809958 · Cited by 123
Current and future alternative therapies for beta-thalassemia major
Dreuzy, E. D., Bhukhai, K., Leboulch, P., & Payen, E. (2016) · Biomedical Journal · doi:10.1016/j.bj.2015.10.001 · Cited by 114
Rychtarcikova, Z., Lettlova, S., Tomkova, V., Korenkova, V., Langerova, L., Simonova, E., Zjablovskaja, P., Alberich-Jorda, M., Neuzil, J., & Truksa, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14093 · Cited by 100
Xie, Y., Tan, Y., Zheng, Y., Du, X., & Liu, Q. (2017) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-017-1463-2 · Cited by 100
Cappellini, M. D., Porter, J. B., Origa, R., Forni, G. L., Voskaridou, E., Galactéros, F., Taher, A. T., Arlet, J., Ribeil, J., Garbowski, M., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.198887 · Cited by 99
MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis
Kindrat, I., Tryndyak, V., de Conti, A., Shpyleva, S., Mudalige, T., Kobets, T., Еrstenyuk, H. M., Beland, F. A., & Pogribny, I. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6004 · Cited by 95
Vadhan‐Raj, S., Abonour, R., Goldman, J. W., Smith, D. A. B., Slapak, C. A., Ilaria, R. L., Tiu, R. V., Wang, X., Callies, S., Cox, J., et al. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0427-x · Cited by 92
Lang, J., Zhao, X., Wang, X., Zhao, Y., Li, Y., Zhao, R., Cheng, K., Li, Y., Han, X., Zheng, X., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b08823 · Cited by 89
An important role of the hepcidin–ferroportin signaling in affecting tumor growth and metastasis
Guo, W., Zhang, S., Chen, Y., Zhang, D., Yuan, L., Cong, H., & Liu, S. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv063 · Cited by 86
Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment
Mertens, C., Mora, J., Ören, B., Grein, S., Winslow, S., Scholich, K., Weigert, A., Malmström, P., Forsare, C., Fernö, M., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1408751 · Cited by 85
The Role of Iron in the Pathogenesis of Atherosclerosis
Kraml, P. (2017) · Physiological Research · doi:10.33549/physiolres.933589 · Cited by 83
Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease
Sheetz, M. J., Barrington, P., Callies, S., Berg, P. H., McColm, J., Marbury, T. C., Decker, B. S., Dyas, G. L., Truhlar, S. M. E., Benschop, R. J., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13877 · Cited by 80
Erythropoietin stimulating agents in the management of anemia of chronic kidney disease
Salifu, M. O. (2008) · Patient Preference and Adherence · doi:10.2147/ppa.s2356 · Cited by 79
Oral ferroportin inhibitor VIT‐2763: First‐in‐human, phase 1 study in healthy volunteers
Richard, F., van Lier, J. J., Roubert, B., Haboubi, T., Göhring, U., & Dürrenberger, F. (2019) · American Journal of Hematology · doi:10.1002/ajh.25670 · Cited by 77
Arezes, J., Foy, N., McHugh, K., Quinkert, D., Benard, S., Sawant, A., Frost, J. N., Armitage, A. E., Pasricha, S., Lim, P. J., et al. (2020) · Blood · doi:10.1182/blood.2019003140 · Cited by 75
The Treatment of Secondary Hemochromatosis
Gattermann, N. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0499 · Cited by 74
Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.
Taetle, R., Castagnola, J., & Mendelsohn, J. M. (1986) · PubMed · Cited by 72
Renders, L., Budde, K., Rosenberger, C., van Swelm, R. P. L., Swinkels, D. W., Dellanna, F., Feuerer, W., Wen, M., Erley, C. M. M., Bader, B. D., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212023 · Cited by 67
Hepcidin and its therapeutic potential in neurodegenerative disorders
Qian, Z., & Ke, Y. (2019) · Medicinal Research Reviews · doi:10.1002/med.21631 · Cited by 65
Divalent metal transporter 1 is a hypoxia‐inducible gene
Qian, Z., Wu, X. M., Fan, M., Yang, L., Du, F., Yung, W., & Ke, Y. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22485 · Cited by 64
Boulad, F., Wang, X., Qu, J., Taylor, C., Ferro, L., Karponi, G., Bartido, S. M., Giardina, P. J., Heller, G., Prockop, S. E., et al. (2014) · Blood · doi:10.1182/blood-2013-06-507178 · Cited by 64
You, K., Su, F., Liu, L., Lv, X., Zhang, J., Zhang, Y., & Liu, B. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3055-4 · Cited by 62
Horniblow, R. D., Bedford, M., Hollingworth, R., Evans, S. C., Sutton, E., Lal, N., Beggs, A. D., Iqbal, T. H., & Tselepis, C. (2017) · Cancer Science · doi:10.1111/cas.13234 · Cited by 61
10. MANGANESE: ITS ROLE IN DISEASE AND HEALTH
Erikson, K. M., & Aschner, M. (2019) · De Gruyter eBooks · doi:10.1515/9783110527872-010 · Cited by 58
Correction: Alpha-Synuclein Is a Cellular Ferrireductase
Davies, P., Moualla, D., & Brown, D. R. (2011) · PLoS ONE · doi:10.1371/annotation/900a5247-7d03-4686-a544-5f7f64c0aac5 · Cited by 57
Decreased expression of ferroportin in prostate cancer
Xue, D., Zhou, C., Shi, Y., Lü, H., & He, X. (2015) · Oncology Letters · doi:10.3892/ol.2015.3363 · Cited by 53
Patel, D., Xu, C., Nagarajan, S., Liu, Z., Hemphill, W. O., Shi, R., Uversky, V. N., Caldwell, G. A., Caldwell, K. A., & Witt, S. N. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy059 · Cited by 45
Transferrin Receptor 1: A Target for Antibody-Mediated Cancer Therapy
Daniels‐Wells, T. R., & Penichet, M. L. (2016) · Immunotherapy · doi:10.2217/imt-2016-0050 · Cited by 40
Diagnosis and Treatment of Genetic HFE-Hemochromatosis: The Danish Aspect
Milman, N. T., Schiødt, F. V., Junker, A. E., & Magnussen, K. (2019) · Gastroenterology Research · doi:10.14740/gr1206 · Cited by 39
Altamura, S., Schaeper, U., Dames, S., Löffler, K., Eisermann, M., Frauendorf, C., Müdder, K., Neves, J., & Muckenthaler, M. U. (2019) · HemaSphere · doi:10.1097/hs9.0000000000000301 · Cited by 37
Saliba, A. N., Rassi, F. A. E., & Taher, A. T. (2015) · Expert Review of Hematology · doi:10.1586/17474086.2016.1126176 · Cited by 31
Expression of transferrin receptors during erythroid maturation
Horton, M. A. (1983) · Experimental Cell Research · doi:10.1016/0014-4827(83)90415-9 · Cited by 30
Lal, A., Locatelli, F., Kwiatkowski, J. L., Kulozik, A. E., Yannaki, E., Porter, J. B., Thuret, I., Sauer, M. G., Elliot, H., Chen, Y., et al. (2019) · Blood · doi:10.1182/blood-2019-128482 · Cited by 25
Prolyl hydroxylase domain-2 (PHD2) inhibition may be a better therapeutic strategy in renal anemia
Soni, H. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.02.008 · Cited by 21
Identifying poor adherence to antihypertensive medications in patients with resistant hypertension
Mackenzie, I. S., & MacDonald, T. M. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13806 · Cited by 16
3D cell technologies head to the R&D assembly line
Kingwell, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.282 · Cited by 15
McCaleb, M. L., Lickliter, J. D., Dibble, A., Schneider, E., Aghajan, M., Guo, S., Hughes, S. G., Geary, R. S., & Monia, B. P. (2018) · Blood · doi:10.1182/blood-2018-99-115339 · Cited by 15
Abe, N., Tsuchida, T., Yasuda, S.-I., & Oka, K. (2019) · Biology Open · doi:10.1242/bio.040519 · Cited by 15
Altamura, S., Altamura, S., Muckenthaler, M. U., Dames, S., Frauendorf, C., Schubert, S., Aleku, M., Vadolas, J., Grigoriadis, G., & Zügel, U. (2018) · Blood · doi:10.1182/blood-2018-99-110163 · Cited by 12
A sense of immunity: Scientists are detailing the immune system as never before
Keener, A. B. (2015) · Nature Medicine · doi:10.1038/nm0115-3 · Cited by 4
Research works printed but not linked: 7
- Laurell, 1951, Analytical review: what is the function of transferrin in plasma?, Blood, 6, 183, 10.1182/blood.V6.2.183.183 · doi:10.1182/blood.v6.2.183.183
- Faulk, 1990, Preliminary clinical study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients, Mol. Biother., 2, 57
- Van Vuren, 2019, Proton pump inhibition for secondary hemochromatosis in hereditary anemia, a phase III placebo controlled randomized cross-over trial in progress, Blood, 134, 960, 10.1182/blood-2019-124059 · doi:10.1182/blood-2019-124059
- Ward, 2019, Ironing out the brain, Met. Ions Life Sci., 19
- Xie, 2018, DMT 1 inhibitor ebselen inhibits iron-induced amyloidogenic APP processing, Int. J. Clin. Exp. Med., 11, 7907
- Holmes, 2018, A potential therapy for beta-thalassemia (ST-400) and sickle cell disease (BIVV003), Biol. Blood Marrow Transplant., 24, S172, 10.1016/j.bbmt.2017.12.105 · doi:10.1016/j.bbmt.2017.12.105
- Zipkin, M. CRISPR’s ‘magnificent moment’ in the clinic. Nat. Biotechnol. Published online December 6, 2019. https://doi.org/10.1038/d41587-019-00035-2. · doi:10.1038/d41587-019-00035-2
Cited by
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
The interaction between ferroptosis and inflammatory signaling pathways
Chen, Y., Fang, Z.-M., Yi, X., Wei, X., & Jiang, D.-S. (2023) · Cell Death & Disease · doi:10.1038/s41419-023-05716-0 · Cited by 567
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Moazzam, M., Zhang, M., Hussain, A., Yu, X., Huang, J., & Huang, Y. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.01.005 · Cited by 230
Iron Metabolism: State of the Art in Hypoxic Cancer Cell Biology
Liu, S., Cao, X., Wang, D., & Zhu, H. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109199 · Cited by 31
Metadata
- Authors
- Roemhild, K., von Maltzahn, F., Weiskirchen, R., Knüchel, R., von Stillfried, S., & Lammers, T.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2021-08
- Volume
- 42
- Issue
- 8
- Pages
- 640-656
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W3171474857
- Cited by
- 302
- References
- 120
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- ERC
- DFG
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.